Improving publication rates of biomarker results from cancer trials
- PMID: 23052254
- DOI: 10.1158/1078-0432.CCR-12-2856
Improving publication rates of biomarker results from cancer trials
Abstract
Mandatory nondiagnostic biopsies for biomarker research pose risk and inconvenience to patients with cancer that should be justified by the knowledge gained. This commentary reflects on the publication by Freeman and Kimmelman, which points to a potentially low publication rate of biomarker results from cancer clinical trials requiring nondiagnostic biopsies.
©2012 AACR.
Comment on
-
Publication and reporting conduct for pharmacodynamic analyses of tumor tissue in early-phase oncology trials.Clin Cancer Res. 2012 Dec 1;18(23):6478-84. doi: 10.1158/1078-0432.CCR-12-1384. Epub 2012 Aug 21. Clin Cancer Res. 2012. PMID: 22912391
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
